Wine drinkers had 21% lower cardiovascular death; spirits and beer drinkers 9% higher. Whether that is the drink or the drinker is the whole question.
Nine patients with unexplained vision loss unrelated to the disease. EyePoint says excluding them would have met the endpoint — investors reacted to the endpoint, not the post-hoc arithmetic.
A trillion neurons, 46 million images, 15 months — and a $3 million milestone. The gap between those numbers is the honest measure of where AI discovery stands.
The share of global drug sales under patent protection is projected to fall from 12% to 4% by 2030. Sandoz is buying pipeline to meet it.
A $1 billion special dividend before closing, funded partly by new debt. The structure says as much about the deal as the strategic fit.
4,500 cases and 2,060 deaths in Ituri, spreading faster than any previous outbreak. WHO is proposing to randomise contacts individually rather than by ring — a change with real trade-offs.
A third of patients stopped having nightmares entirely. The trial could not show the drug helped PTSD itself — and reports that as a limit, not a footnote.
The vitamin famous as an antioxidant may work against cancer by doing the opposite — and only at concentrations a tablet cannot produce.
A negative result with a practical consequence: if genes explained superagers, a blood test would identify them. It does not.
Short-range contacts fall, long-range contacts rise. The genome is folding differently in diseased brain cells, and folding governs which genes run.
Not silencing the gene — changing how it is read, so the cell skips the section that produces the toxic fragments.
The brain’s resident immune cells thin out between 50 and 75 and are replaced by inflammatory cells resembling blood-borne immune cells. That substitution may be what makes age the dominant dementia risk factor.